Primer Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

At Primer Ventures, we believe in the power of innovation and are committed to partnering with visionary entrepreneurs to transform healthcare.

Venture capitalprimerventures.comSince 2026-07-07

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$67.4M

across 1 round

LATEST ROUND

Series D+ · $67.4M · 2026-07-07

CO-INVESTORS

named beside it

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

A cancer therapeutics company developing targeted treatments for hard-to-treat tumours

Series D+$67.4M2026-07-076 [ HISTORY ]

Company	Round	Amount	Announced	Role
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours	Series D+ Verified against 1 of 6 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$67.4M	2026-07-07	[ PART ]